What happened
Robert Gries JR, a director at Slide Insurance Holdings (NYSE: SLDE), completed two stock sales totaling 56,424 shares, producing proceeds that exceeded $1,000,000. The transactions took place on March 17 and March 18, 2026, and were executed under a pre-established 10b5-1 trading arrangement adopted on December 12, 2025.
Breakdown of the sales
- On March 17, Gries sold 28,212 shares at a weighted average price of $18.35, for aggregate proceeds of $517,504. The traded prices for that tranche ranged between $18.21 and $18.45.
- On March 18, he sold an additional 28,212 shares at a weighted average price of $17.85, generating $503,770. The price range on that day was $17.50 to $18.27.
Holdings after the transactions
Following these dispositions, Gries directly holds 843,804 shares of Slide Insurance common stock and has indirect ownership of 1,974,841 shares through GRM Family Limited Partnership.
Valuation and fundamentals cited
Despite the insider sales, InvestingPro data included in reporting indicates Slide Insurance may be trading below its calculated Fair Value. The company is shown to have a free cash flow yield of 36% and a financial health score of 3.82, labeled as "EXCELLENT." These metrics are presented alongside the insider activity in the public filings and market data referenced.
Recent operating results and analyst reaction
Slide Insurance reported robust fourth-quarter 2025 results. The company posted earnings per share of $1.23 versus analyst expectations of $0.71, representing a 73.24% earnings surprise. Quarterly revenue reached $347 million, up from $238.5 million a year earlier. In response to those results and noted improvements in loss trends, Keefe, Bruyette & Woods raised its price target on Slide Insurance to $23 from $22 and reiterated an Outperform rating.
Context and limitations
The sale of shares by a director occurred under a predetermined 10b5-1 program, which is designed to allow insiders to trade according to a plan established in advance. The data points on valuation and company health are reported as part of InvestingPro analytics and the cited financial metrics and analyst action reflect information disclosed alongside the transactions and earnings release.
Note: Additional administrative information about the production of this report is provided in the disclosure field.